SCHEMBL2617482

SCHEMBL2617482

CC(C)(C)[Si](C)(C)CC=O

nearest known ligand 0.30

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.30
MAPK1 P28482 1/20 0.30
TDP1 Q9NUW8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9506612 0.71 NR1H2 (0.31)
SCHEMBL441396 0.67
SCHEMBL9507326 0.65
SCHEMBL27580168 0.65
SCHEMBL27098286 0.65
SCHEMBL4634129 0.65
SCHEMBL15863920 0.63
SCHEMBL29501847 0.63
SCHEMBL8926659 0.61
SCHEMBL14727437 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 42 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119613425-A Synthesis method of curved Bei Ti fixed five-ring core skeleton 南方科技大学 2025-03-14 CN claimed
CN-118994019-A Process for the preparation of (R) -2- ((R) -2' -amino-4 ',5' -dihydro-1 ' H-imidazol-4 ' -yl) -6-methylhept-5-enoate derivatives 临沂大学 2024-11-22 CN claimed
US-20250250226-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NITTO DENKO CORP (JP) 2025-08-07 US disclosed
WO-2025124429-A1 AROMATIC AMINE COMPOUND, AND PHARMACEUTICAL COMPOSITION AND USE THEREOF 北京康辰药业股份有限公司 2025-06-19 WO disclosed
US-12319643-B2 Ionizable compounds and compositions and uses thereof NITTO DENKO CORPORATION (JP) 2025-06-03 US disclosed
CN-119930618-A Polysubstituted aryl derivative and preparation method and application thereof 浙江海正药业股份有限公司 2025-05-06 CN disclosed
WO-2025077773-A1 NOVEL TYPE I TOPOISOMERASE INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF 上海翊维康医药有限责任公司 2025-04-17 WO disclosed
CN-119613425-A Synthesis method of curved Bei Ti fixed five-ring core skeleton 南方科技大学 2025-03-14 CN disclosed
CN-119546585-A Preparation, application and application of indole compound 上海济煜医药科技有限公司 2025-02-28 CN disclosed
CN-119264153-A Substituted tricyclic derivatives, pharmaceutical compositions and uses thereof 上海海雁医药科技有限公司 2025-01-07 CN disclosed
CN-119192175-A Compound, pharmaceutical composition and application thereof 北京康辰药业股份有限公司 2024-12-27 CN disclosed
EP-3313449-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF Nitto Denko Corporation (JP) 2018-05-02 EP disclosed
CN-107708739-A Ionizable compound, composition and their purposes 日东电工株式会社 2018-02-16 CN disclosed
WO-2017120429-A1 SELECTIVE INHIBITORS OF CLINICALLY IMPORTANT MUTANTS OF THE EGFR TYROSINE KINASE CS Pharmasciences, Inc. (US) 2017-07-13 WO disclosed
WO-2016210190-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NITTO DENKO CORPORATION (JP) 2016-12-29 WO disclosed
US-20160376229-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NITTO DENKO CORPORATION (JP) 2016-12-29 US disclosed
US-8163919-B2 Imidazopyridinyl benzamide mitotic kinesin inhibitors CYTOKINETICS, INCORPORATED (US) 2012-04-24 US disclosed
US-20090306127-A1 Certain Chemical Entities, Compositions and Methods CYTOKINETICS, INC 2009-12-10 US disclosed
EP-0745073-B1 5-SUBSTITUTED DERIVATIVES OF MYCOPHENOLIC ACID SYNTEX INC (US) 2000-07-12 EP disclosed
CN-1030918-C 4-substituted alkyl carbapenem antibiotics BRISTOL MYERS SQUIBB CO (US) 1996-02-07 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250250226-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NCL, RNASE1, RNMT ALDH1A1 3118/4885MAPK1 4311/4885TDP1 1223/4885
US-20160376229-A1 IONIZABLE COMPOUNDS AND COMPOSITIONS AND USES THEREOF NCL, CHMP4B, RNASE1 ALDH1A1 3075/4885MAPK1 4553/4885TDP1 1220/4885
US-20090306127-A1 Certain Chemical Entities, Compositions and Methods KIF5B, KIF2C, PLK1 ALDH1A1 1977/4885MAPK1 2332/4885TDP1 231/4885
US-12319643-B2 Ionizable compounds and compositions and uses thereof NCL, RNASE1, RNMT ALDH1A1 3118/4885MAPK1 4311/4885TDP1 1223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.